Patent Assignment
Reel/Frame 015662/0810
Assignment of Assignor's Interest
Recorded: 2005-02-04
Pages: 3
Assignor
ELANEX PHARMA (IOM) LTD.
Executed: 2001-08-24
Assignee
BAXTER HEALTHCARE S.A.
HERTISTRASSE 2, WALLISELLEN, KANTON, ZURICH, CH-8306, SWITZERLAND
Covered Property
(1)
Therapeutic Methods for Treating Subjects with a Recombinant Erythropoietin Having High Activity and Reduced Side Effects
Patent:
7,078,376 →
Application:
09/637,962 →
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Agreement
Feb 4, 2005
From: THOMPSON, LAWRENCE H.
To: ELANEX PHARMA (IOM), LTD.
Reel/Frame 015746/0792 →
Assignment of Assignor's Interest
Aug 17, 2015
From: BAXTER HEALTHCARE S.A.
To: BAXALTA GMBH; BAXALTA INCORPORATED
Reel/Frame 036357/0001 →
Corrective Assignment to Correct the Conveying Party Data Previously Recorded on Reel 036357 Frame 0001. Assignor(S) Hereby Confirms the Assignment from Baxter Healthcare Sa to Baxalta Gmbh and Baxalta Incorporated.
Aug 21, 2015
From: BAXTER HEALTHCARE SA
To: BAXALTA GMBH; BAXALTA INCORPORATED
Reel/Frame 036412/0001 →
Assignment of Assignor's Interest
Jan 9, 2018
From: BAXALTA INCORPORATED; BAXALTA GMBH
To: BAXTER INTERNATIONAL INC.; BAXTER HEALTHCARE SA
Reel/Frame 044578/0434 →